RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

J Natl Cancer Inst. 2015 Aug 6;107(9):djv204. doi: 10.1093/jnci/djv204. Print 2015 Sep.

¹ Academic Unit of Surgery, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, Scotland (LKPV, PGH, DCM, NBJ); West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, Scotland (LKPV, CWS, EJD, CRC, CJM, PGH, DCM, NBJ).
² Academic Unit of Surgery, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, Scotland (LKPV, PGH, DCM, NBJ); West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, Scotland (LKPV, CWS, EJD, CRC, CJM, PGH, DCM, NBJ). nigel.jamieson@glasgow.ac.uk.

No abstract available

Publication types